Over the past 12 months, 0 insiders at Neoleukin Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on NLTX: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 23 | Baker Brothers Life Sciences LpDirector,TenPercentOwner | BUY | 93.1K | $0.69 | $64K |
| Aug 16, 23 | Baker Brothers Life Sciences LpDirector,TenPercentOwner | BUY | 207.7K | $0.68 | $141K |
| Aug 15, 23 | Baker Brothers Life Sciences LpDirector,TenPercentOwner | BUY | 1.74M | $0.67 | $1.1M |
| Aug 11, 23 | Sean Michael SmithInterim CFO, Prin Acct Off | SELL | 1.3K | $0.62 | $820 |
| Apr 3, 23 | Priti PatelOther | SELL | 3.8K | $0.69 | $3K |
| Feb 2, 23 | Priti PatelChief Medical Officer | SELL | 14.4K | $0.60 | $9K |
| Feb 2, 23 | Sean Michael SmithPrincipal Accounting Officer | SELL | 3.3K | $0.60 | $2K |
| Aug 10, 22 | Sean Michael SmithPrincipal Accounting Officer | SELL | 1.7K | $0.99 | $2K |
| May 2, 22 | Priti PatelChief Medical Officer | SELL | 5.5K | $1.22 | $7K |
| Aug 25, 21 | Jonathan G DrachmanPresident and CEO | BUY | 25.0K | $6.45 | $161K |
| Aug 24, 21 | Jonathan G DrachmanPresident and CEO | BUY | 100.0K | $6.11 | $611K |
Over the past 12 months, insiders at Neoleukin Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on NLTX, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market NLTX insider purchase in our data was $1.1M by Baker Brothers Life Sciences Lp, Director,TenPercentOwner, filed on Aug 15, 23.
0 different insiders at Neoleukin Therapeutics, Inc. filed open-market SEC Form 4 transactions on NLTX over the last 12 months.
InsiderTape plots every NLTX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Neoleukin Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →